Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Malignant lymphomas--a showpiece?].

J P Obrecht

    Schweizerische Medizinische Wochenschrift
    |September 10, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Advances in lymphoma treatment, particularly Hodgkin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of Cutaneous T-cell Lymphoma with Cyclosporin A: Case Report and Literature Review.

    Leukemia & lymphoma·2016
    Same author

    Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997
    Same author

    First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1994
    Same author

    [Breast carcinoma and later hormonal osteoporosis prevention].

    Deutsche medizinische Wochenschrift (1946)·1992
    Same author

    Interferon-gamma and interleukin-4 down-regulate soluble CD14 release in human monocytes and macrophages.

    Journal of leukocyte biology·1992
    Same author

    [Diagnostic problems in local recurrence after breast saving treatment].

    Helvetica chirurgica acta·1992
    Same journal

    Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Boeck's disease as a tuberculous syndrome.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Enteral primary tubercular complexes

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Tuberculous stenoses of the large bronchi.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    About the enzyme action.

    Schweizerische medizinische Wochenschrift·2010
    See all related articles

    Area of Science:

    • Oncology and Hematology
    • Pathology and Immunology

    Context:

    • Malignant lymphoma treatment has seen significant progress over the last 10-20 years.
    • Multidisciplinary collaboration among pathologists, immunologists, and oncologists has driven advancements.
    • Hodgkin's lymphoma and non-Hodgkin lymphoma present distinct challenges and treatment outcomes.

    Purpose:

    • To review the progress in malignant lymphoma treatment, focusing on Hodgkin's lymphoma.
    • To highlight the key factors for achieving cures: histopathologic typing, staging, and prognostic factors.
    • To discuss the curability of different lymphoma subtypes and stages.

    Summary:

    • Hodgkin's lymphoma shows high cure rates (90% in early stages, >60% advanced) with radiotherapy.
    • Non-Hodgkin lymphoma cure rates vary; Stage I is largely curable, while advanced stages are challenging.

    Related Experiment Videos

  • The histiocytic subtype of non-Hodgkin lymphoma is curable in over 40% of advanced cases with chemotherapy.

    • Impact:

    • Accurate histopathologic classification and staging are crucial for effective lymphoma treatment planning.
    • Chemotherapy has transformed outcomes for previously fatal lymphoma subtypes.
    • Future research holds potential for further improving lymphoma cure rates.